The results showed that SPI1 mRNA expression was upregulated significantly in GC and certain other tumors, whereas it was downregulated in colon cancer, lung cancer, and leukemia; this difference may have been caused by the different potential pathogenic mechanisms involved in these cancers. This evidence concerns the gene SPI1 and lung carcinoma.